Home NDC 82736-017 AntiLoss Terramar SH
Product NDC 82736-017
11-digit product format 827360017
Labeler code 82736
Product ID 82736-017_dfd8be45-7a6a-acf3-e053-2a95a90a4b38
Type HUMAN OTC DRUG
Nonproprietary name PROPYLENE GLYCOL 1 - OLEATE
Dosage form CREAM
Route TOPICAL
Labeler TERRAMAR BRANDS S de RL de CV
Application M032
Marketing category OTC MONOGRAPH FINAL
Marketing start 2022-05-26
Marketing end 0000-00-00
Substance PROPYLENE GLYCOL 1-OLEATE; SALICYLIC ACID
Active strength 0 g/g; g/g
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 30 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 82736-017-01 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 82736-017-01 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 82736-017-01 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 82736-017-01 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 82736-017-01 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 82736-017-01 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 82736-017-01 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 82736-017-01 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 82736-017-01 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 82736-017-01 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 82736-017-01 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 82736-017-01 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 82736-017-01 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 82736-017-01 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 82736-017-01 1332a3947898…d4bfe170f9cd…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 82736-017-01 AntiLoss Terramar SH 1 g in 1 CARTON CREAM 1 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 82736-017 HYDRATING FACIAL CREAM SPF 15 DRY SKIN (ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, BENZOPHENONE3) CREAM BALM WITH NATURAL BUTTERS SPF15 (OCTINOXATE) LIPSTICK EYELASH AND EYEBROW LENGTHENER (PROPYLENE GLYCOL) CREAM FACIAL PRIMER PROTECTOR SPF 50 (HOMOSALATE) CREAM HYDRATING FACIAL SPF 15 MIX NORMAL SKIN .......RAY FACIAL PRIMER PROTECTOR SPF 50 (HOMOSALATE, BENZOPHENONE-3, OCTOCRYLENE, ETHYLEXYL SALICYLATE, BUTYL METHOXYDIBENZOYLMETHANE) CREAM FOCUSED CORRECTIVE (WATER (AQUA), BUTYLENE GLYCOL, PEG-60 ALMOND GLYCERIDES, CAPRYLYL GLYCOL, GLYCERIN, CARBOMER, NORDIHYDROGUAIARETIC ACID, OLEANOLIC ACID, BETA VULGARIS (BEET) ROOT EXTRACT, OENOTHERA BIENNIS (EVENING PRIMROSE) LEAF EXTRACT) CREAM [TERRAMAR BRANDS S DE RL DE CV] 1 Legacy NDC, 1 package rows 20221018_dfd8be45-7a69-acf3-e053-2a95a90a4b38.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 21 of 31 · 615 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 82736-017-01 82736001701 1 g in 1 CARTON (82736-017-01) 1 g 2022-05-26 0000-00-00 No No Current